Distinct Prognostic Values of Phospholipase C Beta Family Members for Non-Small Cell Lung Carcinoma

Table 3

Enrichment analysis of KEGG pathways of PLCB family members.

Term	Count	%	P value	FDR	Genes
hsa00562:Inositol phosphate metabolism	4	0.575539568	1.04E-06	9.62E-04	PLCB3, PLCB4, PLCB1, PLCB2
hsa04540:Gap junction	4	0.575539568	2.00E-06	0.00184768	PLCB3, PLCB4, PLCB1, PLCB2
hsa04310:Wnt signaling pathway	4	0.575539568	7.80E-06	0.007215304	PLCB3, PLCB4, PLCB1, PLCB2
hsa04020:Calcium signaling pathway	4	0.575539568	1.71E-05	0.015825071	PLCB3, PLCB4, PLCB1, PLCB2
hsa04062:Chemokine signaling pathway	4	0.575539568	1.92E-05	0.017766346	PLCB3, PLCB4, PLCB1, PLCB2
hsa04015:Rap1 signaling pathway	4	0.575539568	2.77E-05	0.025615883	PLCB3, PLCB4, PLCB1, PLCB2
hsa05200:Pathways in cancer	4	0.575539568	1.83E-04	0.168911037	PLCB3, PLCB4, PLCB1, PLCB2

Notes: PLCB2, phospholipase C beta 2; PLCB3, phospholipase C beta 3; PLCB4, phospholipase C beta 4; FDR, false discovery rate.